Bridging the gap between regulatory FDA compliance and modern software delivery

Logo
Presented by

Kevin Thompson, Jason Tepfendardt

About this talk

Tricentis and Tx3 executives share the details of Tricentis’ just-announced acquisition of Tx3, which extends our industry-leading continuous testing portfolio with automated digital validation for life sciences and healthcare organizations. In this webinar, you will learn how the two companies are coming together to enable FDA-regulated organizations to modernize application delivery and reduce risk by integrating digital validation and compliance management with Agile and DevOps workflows. Our executives will share what this acquisition means for our customers and the life sciences industry, as well as how you can leverage Tx3 to modernize your software delivery processes, while dramatically reducing the time and expense associated with traditional validation methods.
Related topics:

More from this channel

Upcoming talks (2)
On-demand talks (183)
Subscribers (13911)
Tricentis is the global leader in continuous testing and automation, widely credited for rein- venting software testing for DevOps and agile environments. The Tricentis AI-based, automation platform enables enterprises to accelerate their digital transformation by dramatically increasing soft- ware release speed, reducing costs, and improving software quality. Tricentis has been widely recognized as the leader by all major industry analysts, including being named a leader in Gartner’s Magic Quadrant five years in a row. Tricentis has more than 1,800 customers, including the largest brands in the world, such as Accenture, Coca-Cola, Nationwide Insurance, Allianz, Telstra, Dolby, RBS, and Zappos. To learn more, visit https://www.tricentis.com or follow us on LinkedIn, Twitter, and Facebook.